Immunocompromised Host clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens

    open to eligible people ages 18-80

    Given the need for a more sensitive pathogen detection test in patients with immunocompromised pneumonia, this study will evaluate the performance of the Karius Test, a novel NGS blood test for the diagnosis of infectious diseases. We will compare the performance of the Karius Test to the results of microbiologic tests obtained as part of usual care for immunocompromised patients undergoing evaluation for suspected pneumonia.

    San Francisco, California and other locations

Our lead scientists for Immunocompromised Host research studies include .

Last updated: